» Articles » PMID: 23553591

Hepatic Macrophages but Not Dendritic Cells Contribute to Liver Fibrosis by Promoting the Survival of Activated Hepatic Stellate Cells in Mice

Abstract

Unlabelled: Although it is well established that hepatic macrophages play a crucial role in the development of liver fibrosis, the underlying mechanisms remain largely elusive. Moreover, it is not known whether other mononuclear phagocytes such as dendritic cells (DCs) contribute to hepatic stellate cell (HSC) activation and liver fibrosis. We show for the first time that hepatic macrophages enhance myofibroblast survival in a nuclear factor kappa B (NF-κB)-dependent manner and thereby promote liver fibrosis. Microarray and pathway analysis revealed no induction of HSC activation pathways by hepatic macrophages but a profound activation of the NF-κB pathway in HSCs. Conversely, depletion of mononuclear phagocytes during fibrogenesis in vivo resulted in suppressed NF-κB activation in HSCs. Macrophage-induced activation of NF-κB in HSCs in vitro and in vivo was mediated by interleukin (IL)-1 and tumor necrosis factor (TNF). Notably, IL-1 and TNF did not promote HSC activation but promoted survival of activated HSCs in vitro and in vivo and thereby increased liver fibrosis, as demonstrated by neutralization in coculture experiments and genetic ablation of IL-1 and TNF receptor in vivo. Coculture and in vivo ablation experiments revealed only a minor contribution to NF-κB activation in HSCs by DCs, and no contribution of DCs to liver fibrosis development, respectively.

Conclusion: Promotion of NF-κB-dependent myofibroblast survival by macrophages but not DCs provides a novel link between inflammation and fibrosis.

Citing Articles

Hepatic stellate cells control liver zonation, size and functions via R-spondin 3.

Sugimoto A, Saito Y, Wang G, Sun Q, Yin C, Lee K Nature. 2025; .

PMID: 40074890 DOI: 10.1038/s41586-025-08677-w.


Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets.

Guan F, Wang R, Yi Z, Luo P, Liu W, Xie Y Signal Transduct Target Ther. 2025; 10(1):93.

PMID: 40055311 PMC: 11889221. DOI: 10.1038/s41392-025-02124-y.


Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response.

Baquero C, Iniesta-Gonzalez M, Palao N, Fernandez-Infante C, Cueto-Remacha M, Mancebo J J Pathol. 2025; 265(4):502-517.

PMID: 39989399 PMC: 11880977. DOI: 10.1002/path.6403.


EGF receptor in organ development, tissue homeostasis and regeneration.

Tito C, Masciarelli S, Colotti G, Fazi F J Biomed Sci. 2025; 32(1):24.

PMID: 39966897 PMC: 11837477. DOI: 10.1186/s12929-025-01119-9.


Inhibition of RAC1 activator DOCK2 ameliorates cholestatic liver injury via regulating macrophage polarisation and hepatic stellate cell activation.

Qiu J, Qu Y, Li Y, Li C, Wang J, Meng L Biol Direct. 2025; 20(1):21.

PMID: 39923106 PMC: 11807328. DOI: 10.1186/s13062-025-00612-3.


References
1.
Radaeva S, Sun R, Jaruga B, Nguyen V, Tian Z, Gao B . Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology. 2006; 130(2):435-52. DOI: 10.1053/j.gastro.2005.10.055. View

2.
Karlmark K, Weiskirchen R, Zimmermann H, Gassler N, Ginhoux F, Weber C . Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology. 2009; 50(1):261-74. DOI: 10.1002/hep.22950. View

3.
Friedman S . Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008; 88(1):125-72. PMC: 2888531. DOI: 10.1152/physrev.00013.2007. View

4.
Jiao J, Sastre D, Fiel M, Lee U, Ghiassi-Nejad Z, Ginhoux F . Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression. Hepatology. 2011; 55(1):244-55. PMC: 3245345. DOI: 10.1002/hep.24621. View

5.
Kornek M, Popov Y, Libermann T, Afdhal N, Schuppan D . Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells. Hepatology. 2010; 53(1):230-42. PMC: 3505073. DOI: 10.1002/hep.23999. View